TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs10927101
log Bayes Factor = <0.0001
Chromosome 1   position 244,173,872  (GRCh37) Explore rs10927101 on Ensembl!
Variant rs10927101 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.968 0.032
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.975 0.025
T42.0 Hydantoin derivatives
0.000 0.978 0.022
S92.30 Fracture of metatarsal bone (closed)
0.000 0.980 0.020
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.980 0.020
T42.1 Iminostilbenes
0.000 0.980 0.020
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.981 0.019
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.982 0.018
T42.3 Barbiturates
0.000 0.982 0.018
T42.2 Succinimides and oxazolidinediones
0.000 0.982 0.018
S92.3 Fracture of metatarsal bone
0.000 0.986 0.014
C83.3 Large cell (diffuse)
0.012 0.988 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.012 0.988 0.000
T42.4 Benzodiazepines
0.000 0.989 0.011
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.989 0.011
S92.31 Fracture of metatarsal bone (open)
0.000 0.989 0.010
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.989 0.011
T43.2 Other and unspecified antidepressants
0.000 0.990 0.010
C83.7 Burkitt's tumour
0.010 0.990 0.000
C85.1 B-cell lymphoma, unspecified
0.010 0.990 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.990 0.010
S92 Fracture of foot, except ankle
0.000 0.990 0.010
C83.1 Small cleaved cell (diffuse)
0.010 0.990 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.010 0.990 0.000
Z92.4 Personal history of major surgery, not elsewhere classified
0.000 0.990 0.010
C92 Myeloid leukaemia
0.010 0.990 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.990 0.010
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.990 0.010
C92.1 Chronic myeloid leukaemia
0.009 0.991 0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.009 0.991 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.991 0.009
S92.0 Fracture of calcaneus
0.000 0.991 0.009
S92.2 Fracture of other tarsal bone(s)
0.000 0.991 0.009
C91 Lymphoid leukaemia
0.009 0.991 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.009 0.991 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.991 0.009
S92.7 Multiple fractures of foot
0.000 0.991 0.009
C92.0 Acute myeloid leukaemia
0.009 0.991 0.000
Z71.6 Tobacco abuse counselling
0.009 0.991 0.000
C93 Monocytic leukaemia
0.008 0.991 0.000
C83.6 Undifferentiated (diffuse)
0.008 0.991 0.000
C83.5 Lymphoblastic (diffuse)
0.008 0.991 0.000
C83.4 Immunoblastic (diffuse)
0.008 0.991 0.000
C83.2 Mixed small and large cell (diffuse)
0.008 0.991 0.000
S92.00 Fracture of calcaneus (closed)
0.000 0.992 0.008
Z71 Persons encountering health services for other counselling and medical advice, not elsewhere classified
0.008 0.992 0.000
Z71.1 Person with feared complaint in whom no diagnosis is made
0.008 0.992 0.000
J35.0 Chronic tonsillitis
0.000 0.992 0.008
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.992 0.008
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.992 0.008
C92.7 Other myeloid leukaemia
0.008 0.992 0.000
Z71.8 Other specified counselling
0.008 0.992 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.992 0.008
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.992 0.008
T43.9 Psychotropic drug, unspecified
0.000 0.992 0.008
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.992 0.008
S92.20 Fracture of other tarsal bone(s) (closed)
0.000 0.992 0.008
C86 Other specified types of T/NK-cell lymphoma
0.008 0.992 0.000
C92.4 Acute promyelocytic leukaemia
0.008 0.992 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.992 0.008
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.992 0.008
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.992 0.008
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.992 0.008
Z71.4 Alcohol abuse counselling and surveillance
0.008 0.992 0.000
C91.5 Adult T-cell leukaemia
0.008 0.992 0.000
C95 Leukaemia of unspecified cell type
0.008 0.992 0.000
S92.1 Fracture of talus
0.000 0.992 0.008
S92.9 Fracture of foot, unspecified
0.000 0.992 0.008
C94 Other leukaemias of specified cell type
0.008 0.992 0.000
S92.70 Multiple fractures of foot (closed)
0.000 0.992 0.007
C93.1 Chronic monocytic leukaemia
0.007 0.992 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.007 0.992 0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.007 0.993 0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.007 0.993 0.000
C92.5 Acute myelomonocytic leukaemia
0.007 0.993 0.000
C92.3 Myeloid sarcoma
0.007 0.993 0.000
C92.2 Subacute myeloid leukaemia
0.007 0.993 0.000
T38.1 Thyroid hormones and substitutes
0.000 0.993 0.007
T38.9 Other and unspecified hormone antagonists
0.000 0.993 0.007
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.993 0.007
T38.7 Androgens and anabolic congeners
0.000 0.993 0.007
T38.5 Other oestrogens and progestogens
0.000 0.993 0.007
T38.4 Oral contraceptives
0.000 0.993 0.007
T38.2 Antithyroid drugs
0.000 0.993 0.007
T38.0 Glucocorticoids and synthetic analogues
0.000 0.993 0.007
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.007 0.993 0.000
S92.4 Fracture of great toe
0.000 0.993 0.007
C83.0 Small cell (diffuse)
0.007 0.993 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.993 0.007
T43.6 Psychostimulants with abuse potential
0.000 0.993 0.007
C91.4 Hairy-cell leukaemia
0.007 0.993 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.993 0.007
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.993 0.007
C91.1 Chronic lymphocytic leukaemia
0.007 0.993 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.007 0.993 0.000
C92.9 Myeloid leukaemia, unspecified
0.007 0.993 0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.007 0.993 0.000
C85.0 Lymphosarcoma
0.007 0.993 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.993 0.007
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.993 0.007
T47.7 Emetics
0.000 0.993 0.007
T47.6 Antidiarrhoeal drugs
0.000 0.993 0.007
T47.5 Digestants
0.000 0.993 0.007
T47.3 Saline and osmotic laxatives
0.000 0.993 0.007
T47.2 Stimulant laxatives
0.000 0.993 0.007
T47.0 Histamine H(2)-receptor antagonists
0.000 0.993 0.007
T36 Poisoning by systemic antibiotics
0.000 0.993 0.007
D25.2 Subserosal leiomyoma of uterus
0.000 0.993 0.007
S92.21 Fracture of other tarsal bone(s) (open)
0.000 0.993 0.007
C91.8 Mature B-cell leukaemia Burkitt-type
0.007 0.993 0.000
C91.7 Other lymphoid leukaemia
0.007 0.993 0.000
C91.6 Prolymphocytic leukaemia of T-cell type
0.007 0.993 0.000
C91.3 Prolymphocytic leukaemia
0.007 0.993 0.000
C91.2 Subacute lymphocytic leukaemia
0.007 0.993 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.993 0.007
C88 Malignant immunoproliferative diseases
0.007 0.993 0.000
Z71.2 Person consulting for explanation of investigation findings
0.007 0.993 0.000
C91.9 Lymphoid leukaemia, unspecified
0.007 0.993 0.000
K52.1 Toxic gastro-enteritis and colitis
0.007 0.993 0.000
C81 Hodgkin's disease
0.007 0.993 0.000
I60.9 Subarachnoid haemorrhage, unspecified
0.000 0.993 0.007
T47.4 Other laxatives
0.000 0.993 0.006
S92.71 Multiple fractures of foot (open)
0.000 0.993 0.006
S92.5 Fracture of other toe
0.000 0.993 0.006
C86.5 Angioimmunoblastic T-cell lymphoma
0.006 0.994 0.000
C93.9 Monocytic leukaemia, unspecified
0.006 0.994 0.000
C93.7 Other monocytic leukaemia
0.006 0.994 0.000
C93.3 Juvenile myelomonocytic leukaemia
0.006 0.994 0.000
C93.2 Subacute monocytic leukaemia
0.006 0.994 0.000
C93.0 Acute monocytic leukaemia
0.006 0.994 0.000
C91.0 Acute lymphoblastic leukaemia
0.006 0.994 0.000
Z71.7 Human immunodeficiency virus [HIV] counselling
0.006 0.994 0.000
Z71.5 Drug abuse counselling and surveillance
0.006 0.994 0.000
Z71.0 Person consulting on behalf of another person
0.006 0.994 0.000
S92.40 Fracture of great toe (closed)
0.000 0.994 0.006
C95.1 Chronic leukaemia of unspecified cell type
0.006 0.994 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.994 0.006
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.994 0.006
S92.01 Fracture of calcaneus (open)
0.000 0.994 0.006
Z71.9 Counselling, unspecified
0.006 0.994 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.994 0.006
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.994 0.006
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.994 0.006
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.994 0.006
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.994 0.006
T44.0 Anticholinesterase agents
0.000 0.994 0.006
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.994 0.006
T37.5 Antiviral drugs
0.000 0.994 0.006
T37.4 Anthelminthics
0.000 0.994 0.006
T37.3 Other antiprotozoal drugs
0.000 0.994 0.006
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.994 0.006
T37.1 Antimycobacterial drugs
0.000 0.994 0.006
T37.0 Sulphonamides
0.000 0.994 0.006
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.006 0.994 0.000
C86.4 Blastic NK-cell lymphoma
0.006 0.994 0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.006 0.994 0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.006 0.994 0.000
C86.1 Hepatosplenic T-cell lymphoma
0.006 0.994 0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.006 0.994 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.994 0.006
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.994 0.006
T50.8 Diagnostic agents
0.000 0.994 0.006
C95.9 Leukaemia, unspecified
0.006 0.994 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.994 0.006
T48.5 Anti-common-cold drugs
0.000 0.994 0.006
T48.4 Expectorants
0.000 0.994 0.006
T48.3 Antitussives
0.000 0.994 0.006
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.994 0.006
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.994 0.006
T48.0 Oxytocic drugs
0.000 0.994 0.006
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.994 0.006
T41.5 Therapeutic gases
0.000 0.994 0.006
T41.4 Anaesthetic, unspecified
0.000 0.994 0.006
T41.3 Local anaesthetics
0.000 0.994 0.006
T41.2 Other and unspecified general anaesthetics
0.000 0.994 0.006
T41.1 Intravenous anaesthetics
0.000 0.994 0.006
T41.0 Inhaled anaesthetics
0.000 0.994 0.006
T49.9 Topical agent, unspecified
0.000 0.994 0.006
T49.8 Other topical agents
0.000 0.994 0.006
T49.7 Dental drugs, topically applied
0.000 0.994 0.006
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.994 0.006
T49.5 Ophthalmological drugs and preparations
0.000 0.994 0.006
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.994 0.006
T49.3 Emollients, demulcents and protectants
0.000 0.994 0.006
T49.2 Local astringents and local detergents
0.000 0.994 0.006
T49.1 Antipruritics
0.000 0.994 0.006
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.994 0.006
T50.7 Analeptics and opioid receptor antagonists
0.000 0.994 0.006
T50.5 Appetite depressants
0.000 0.994 0.006
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.994 0.006
T50.1 Loop [high-ceiling] diuretics
0.000 0.994 0.006
T50.0 Mineralocorticoids and their antagonists
0.000 0.994 0.006
S92.10 Fracture of talus (closed)
0.000 0.994 0.006
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.006 0.994 0.000
S00.8 Superficial injury of other parts of head
0.000 0.994 0.006
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.006 0.994 0.000
S92.11 Fracture of talus (open)
0.000 0.994 0.006
C95.7 Other leukaemia of unspecified cell type
0.006 0.994 0.000
C95.2 Subacute leukaemia of unspecified cell type
0.006 0.994 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.994 0.006
S92.91 Fracture of foot, unspecified (open)
0.000 0.994 0.006
S92.90 Fracture of foot, unspecified (closed)
0.000 0.994 0.006
C94.7 Other specified leukaemias
0.006 0.994 0.000
C94.5 Acute myelofibrosis
0.006 0.994 0.000
C94.4 Acute panmyelosis
0.006 0.994 0.000
C94.3 Mast cell leukaemia
0.006 0.994 0.000
C94.2 Acute megakaryoblastic leukaemia
0.006 0.994 0.000
C94.1 Chronic erythraemia
0.006 0.994 0.000
C94.0 Acute erythraemia and erythroleukaemia
0.006 0.994 0.000
C95.0 Acute leukaemia of unspecified cell type
0.006 0.994 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.994 0.006
T86.8 Failure and rejection of other transplanted organs and tissues
0.006 0.994 0.000
L85.8 Other specified epidermal thickening
0.000 0.994 0.006
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.994 0.005
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.994 0.006
C81.2 Mixed cellularity
0.006 0.994 0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.005 0.994 0.000
C96.8 Histiocytic sarcoma
0.005 0.994 0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.005 0.994 0.000
C96.6 Unifocal Langerhans-cell histiocytosis
0.005 0.994 0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.005 0.994 0.000
C96.4 Sarcoma of dendritic cells (accessory cells)
0.005 0.994 0.000
C96.3 True histiocytic lymphoma
0.005 0.994 0.000
C96.2 Malignant mast cell tumour
0.005 0.994 0.000
C96.1 Malignant histiocytosis
0.005 0.994 0.000
C96.0 Letterer-Siwe disease
0.005 0.994 0.000
G12.2 Motor neuron disease
0.000 0.994 0.006
C84.8 Cutaneous T-cell lymphoma, unspecified
0.005 0.994 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.005 0.995 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.005 0.995 0.000
J01.9 Acute sinusitis, unspecified
0.000 0.995 0.005
R82.9 Other and unspecified abnormal finding in urine
0.005 0.995 0.000
C81.1 Nodular sclerosis
0.005 0.995 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.995 0.005
C84.9 Mature T/NK-cell lymphoma, unspecified
0.005 0.995 0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.005 0.995 0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.005 0.995 0.000
C84.3 Lymphoepithelioid lymphoma
0.005 0.995 0.000
C84.2 T-zone lymphoma
0.005 0.995 0.000
C84.1 Sezary's diease
0.005 0.995 0.000
C84.0 Mycosis fungoides
0.005 0.995 0.000
T36.9 Systemic antibiotic, unspecified
0.000 0.995 0.005
T36.8 Other systemic antibiotics
0.000 0.995 0.005
T36.7 Antifungal antibiotics, systemically used
0.000 0.995 0.005
T36.6 Rifamycins
0.000 0.995 0.005
T36.5 Aminoglycosides
0.000 0.995 0.005
T36.4 Tetracyclines
0.000 0.995 0.005
T36.2 Chloramphenicol group
0.000 0.995 0.005
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.995 0.005
T50.4 Drugs affecting uric acid metabolism
0.000 0.995 0.005
C88.9 Malignant immunoproliferative disease, unspecified
0.005 0.995 0.000
C88.7 Other malignant immunoproliferative diseases
0.005 0.995 0.000
C88.3 Immunoproliferative small intestinal disease
0.005 0.995 0.000
C88.2 Gamma heavy chain disease
0.005 0.995 0.000
C88.1 Alpha heavy chain disease
0.005 0.995 0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.005 0.995 0.000
C81.3 Lymphocytic depletion
0.005 0.995 0.000
C82.0 Small cleaved cell, follicular
0.005 0.995 0.000
C84.5 Other and unspecified T-cell lymphomas
0.005 0.995 0.000
T36.0 Penicillins
0.000 0.995 0.005
C82.1 Mixed small cleaved and large cell, follicular
0.005 0.995 0.000
C82.4 Follicular lymphoma grade IIIb
0.005 0.995 0.000
T40.6 Other and unspecified narcotics
0.000 0.995 0.005
G93.3 Postviral fatigue syndrome
0.005 0.995 0.000
C81.7 Other Hodgkin's disease
0.005 0.995 0.000
C81.0 Lymphocytic predominance
0.005 0.995 0.000
C84.4 Peripheral T-cell lymphoma
0.005 0.995 0.000
T40.5 Cocaine
0.000 0.995 0.005
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.995 0.005
H59.8 Other postprocedural disorders of eye and adnexa
0.005 0.995 0.000
C88.0 Waldenstrom's macroglobulinaemia
0.005 0.995 0.000
C82.3 Follicular lymphoma grade IIIa
0.005 0.995 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.995 0.004
T45.8 Other primarily systemic and haematological agents
0.000 0.995 0.004
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.995 0.004
T45.6 Fibrinolysis-affecting drugs
0.000 0.995 0.004
T45.4 Iron and its compounds
0.000 0.995 0.004
T45.3 Enzymes, not elsewhere classified
0.000 0.995 0.004
S92.51 Fracture of other toe (open)
0.000 0.995 0.004
C82.6 Cutaneous follicle centre lymphoma
0.004 0.995 0.000
C82.5 Diffuse follicle centre lymphoma
0.004 0.995 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.995 0.004
T40.8 Lysergide [LSD]
0.000 0.995 0.004
T40.7 Cannabis (derivatives)
0.000 0.995 0.004
T40.3 Methadone
0.000 0.995 0.004
T40.1 Heroin
0.000 0.995 0.004
T40.0 Opium
0.000 0.995 0.004
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.995 0.004
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.004 0.996 0.000
T45.2 Vitamins, not elsewhere classified
0.000 0.996 0.004
I60.8 Other subarachnoid haemorrhage
0.000 0.996 0.004
I60 Subarachnoid haemorrhage
0.000 0.996 0.004
C90.3 Solitary plasmacytoma
0.004 0.996 0.000
C90.1 Plasma cell leukaemia
0.004 0.996 0.000
S92.50 Fracture of other toe (closed)
0.000 0.996 0.004
T36.3 Macrolides
0.000 0.996 0.004
G12 Spinal muscular atrophy and related syndromes
0.000 0.996 0.004
S92.41 Fracture of great toe (open)
0.000 0.996 0.004
C90.2 Plasmacytoma, extramedullary
0.004 0.996 0.000
T45.5 Anticoagulants
0.000 0.996 0.004
E05.9 Thyrotoxicosis, unspecified
0.004 0.996 0.000
I60.4 Subarachnoid haemorrhage from basilar artery
0.000 0.996 0.004
Z71.3 Dietary counselling and surveillance
0.004 0.996 0.000
S00.0 Superficial injury of scalp
0.000 0.996 0.004
J01.0 Acute maxillary sinusitis
0.000 0.996 0.004
T40.4 Other synthetic narcotics
0.000 0.996 0.004
I60.6 Subarachnoid haemorrhage from other intracranial arteries
0.000 0.996 0.004
G11.9 Hereditary ataxia, unspecified
0.000 0.996 0.004
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.996 0.004
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.996 0.004
T46.7 Peripheral vasodilators
0.000 0.996 0.004
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.996 0.004
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.996 0.004
M18.9 Arthrosis of first carpometacarpal joint, unspecified
0.000 0.996 0.004
I05.2 Mitral stenosis with insufficiency
0.000 0.996 0.004
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.004 0.996 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.996 0.004
T45.0 Antiallergic and antiemetic drugs
0.000 0.996 0.003
J01 Acute sinusitis
0.000 0.996 0.004
C82.2 Large cell, follicular
0.003 0.996 0.000
I70.20 Atherosclerosis of arteries of extremities (without gangrene)
0.000 0.996 0.004
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.004 0.996 0.000
I60.3 Subarachnoid haemorrhage from posterior communicating artery
0.000 0.996 0.004
W17.4 Street and highway
0.000 0.996 0.004
T46.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.996 0.003
R82.4 Acetonuria
0.003 0.997 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.997 0.003
R82 Other abnormal findings in urine
0.003 0.997 0.000
T86 Failure and rejection of transplanted organs and tissues
0.003 0.997 0.000
I70.21 Atherosclerosis of arteries of extremities (with gangrene)
0.000 0.997 0.003
I60.5 Subarachnoid haemorrhage from vertebral artery
0.000 0.997 0.003
S00 Superficial injury of head
0.000 0.997 0.003
T86.0 Bone-marrow transplant rejection
0.003 0.997 0.000
I05.1 Rheumatic mitral insufficiency
0.000 0.997 0.003
G11 Hereditary ataxia
0.000 0.997 0.003
G12.9 Spinal muscular atrophy, unspecified
0.000 0.997 0.003
G12.8 Other spinal muscular atrophies and related syndromes
0.000 0.997 0.003
G12.1 Other inherited spinal muscular atrophy
0.000 0.997 0.003
G12.0 Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]
0.000 0.997 0.003
I70.2 Atherosclerosis of arteries of the extremities
0.000 0.997 0.003
I60.7 Subarachnoid haemorrhage from intracranial artery, unspecified
0.000 0.997 0.003
I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation
0.000 0.997 0.003
I05 Rheumatic mitral valve diseases
0.000 0.997 0.003
Y40.8 Other systemic antibiotics
0.003 0.997 0.000
G10-G14 Systemic atrophies primarily affecting the central nervous system
0.000 0.997 0.003
T46.1 Calcium-channel blockers
0.000 0.997 0.003
S00.3 Superficial injury of nose
0.000 0.997 0.003
J01.8 Other acute sinusitis
0.000 0.997 0.003
I05.0 Mitral stenosis
0.000 0.997 0.003
R82.1 Myoglobinuria
0.003 0.997 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.997 0.003
Y40.3 Macrolides
0.003 0.997 0.000
S00.5 Superficial injury of lip and oral cavity
0.000 0.997 0.003
J01.3 Acute sphenoidal sinusitis
0.000 0.997 0.003
J01.1 Acute frontal sinusitis
0.000 0.997 0.003
T86.1 Kidney transplant failure and rejection
0.003 0.997 0.000
S00.7 Multiple superficial injuries of head
0.000 0.997 0.003
J01.2 Acute ethmoidal sinusitis
0.000 0.997 0.003
K35.0 Acute appendicitis with generalised peritonitis
0.003 0.997 0.000
S12.20 Fracture of other specified cervical vertebra (closed)
0.003 0.997 0.000
G10 Huntington's disease
0.000 0.997 0.003
R82.6 Abnormal urine levels of substances chiefly nonmedicinal as to source
0.003 0.997 0.000
R82.3 Haemoglobinuria
0.003 0.997 0.000
R82.2 Biliuria
0.003 0.997 0.000
R82.0 Chyluria
0.003 0.997 0.000
T86.9 Failure and rejection of unspecified transplanted organ and tissue
0.003 0.997 0.000
T86.3 Heart-lung transplant failure and rejection
0.003 0.997 0.000
T86.2 Heart transplant failure and rejection
0.003 0.997 0.000
G11.1 Early-onset cerebellar ataxia
0.000 0.997 0.003
Y85.0 Sequelae of motor-vehicle accident
0.000 0.997 0.003
M25.31 Other instability of joint (Shoulder region)
0.000 0.997 0.003
R82.5 Elevated urine levels of drugs, medicaments and biological substances
0.003 0.997 0.000
G11.8 Other hereditary ataxias
0.000 0.997 0.002
G11.3 Cerebellar ataxia with defective DNA repair
0.000 0.997 0.002
G11.2 Late-onset cerebellar ataxia
0.000 0.997 0.002
G11.0 Congenital nonprogressive ataxia
0.000 0.997 0.002
G14 Postpolio syndrome
0.000 0.997 0.003
Y40.9 Systemic antibiotic, unspecified
0.003 0.997 0.000
M80.98 Unspecified osteoporosis with pathological fracture (Other)
0.003 0.997 0.000
I05.9 Mitral valve disease, unspecified
0.000 0.997 0.003
I05.8 Other mitral valve diseases
0.000 0.997 0.002
I60.2 Subarachnoid haemorrhage from anterior communicating artery
0.000 0.997 0.003
I20.8 Other forms of angina pectoris
0.003 0.997 0.000
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified
0.003 0.997 0.000
G54.9 Nerve root and plexus disorder, unspecified
0.000 0.997 0.003
Y40 Systemic antibiotics
0.003 0.997 0.000
S00.1 Contusion of eyelid and periocular area
0.000 0.998 0.002
G13 Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere
0.000 0.998 0.002
S52.01 Fracture of upper end of ulna (open)
0.000 0.998 0.002
T86.4 Liver transplant failure and rejection
0.002 0.998 0.000
G11.4 Hereditary spastic paraplegia
0.000 0.998 0.002
J01.4 Acute pansinusitis
0.000 0.998 0.002
R76.8 Other specified abnormal immunological findings in serum
0.000 0.998 0.002
I60.1 Subarachnoid haemorrhage from middle cerebral artery
0.000 0.998 0.002
H59.0 Vitreous syndrome following cataract surgery
0.002 0.998 0.000
O63.0 Prolonged first stage (of labour)
0.002 0.998 0.000
S00.4 Superficial injury of ear
0.000 0.998 0.002
R80 Isolated proteinuria
0.002 0.998 0.000
J34.0 Abscess, furuncle and carbuncle of nose
0.000 0.998 0.002
Z85.7 Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
0.002 0.998 0.000
I70 Atherosclerosis
0.000 0.998 0.002
Y40.6 Rifamycins
0.002 0.998 0.000
H59.9 Postprocedural disorder of eye and adnexa, unspecified
0.002 0.998 0.000
Y40.2 Chloramphenicol group
0.002 0.998 0.000
M25.54 Pain in joint (Hand)
0.002 0.998 0.000
C81.9 Hodgkin's disease, unspecified
0.002 0.998 0.000
J35 Chronic diseases of tonsils and adenoids
0.000 0.998 0.002
I70.1 Atherosclerosis of renal artery
0.000 0.998 0.002
R80-R82 Abnormal findings on examination of urine, without diagnosis
0.002 0.998 0.000
G13.8 Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere
0.000 0.998 0.002
G13.2 Systemic atrophy primarily affecting central nervous system in myxoedema
0.000 0.998 0.002
G13.1 Other systemic atrophy primarily affecting central nervous system in neoplastic disease
0.000 0.998 0.002
I70.0 Atherosclerosis of aorta
0.000 0.998 0.002
R82.7 Abnormal findings on microbiological examination of urine
0.002 0.998 0.000
I70.10 Atherosclerosis of renal artery (without gangrene)
0.000 0.998 0.002
Y40.7 Antifungal antibiotics, systemically used
0.002 0.998 0.000
Y40.5 Aminoglycosides
0.002 0.998 0.000
I70.00 Atherosclerosis of aorta (without gangrene)
0.000 0.998 0.002
I12.0 Hypertensive renal disease with renal failure
0.002 0.998 0.000
K46.9 Unspecified abdominal hernia without obstruction or gangrene
0.000 0.998 0.002
Y40.4 Tetracyclines
0.002 0.998 0.000
G13.0 Paraneoplastic neuromyopathy and neuropathy
0.000 0.998 0.002
K63.2 Fistula of intestine
0.000 0.998 0.002
R82.8 Abnormal findings on cytological and histological examination of urine
0.002 0.998 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.998 0.002
H21.0 Hyphaema
0.000 0.998 0.002
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.998 0.002
T24.3 Burn of third degree of hip and lower limb, except ankle and foot
0.002 0.998 0.000
K04.7 Periapical abscess without sinus
0.002 0.998 0.000
J35.1 Hypertrophy of tonsils
0.000 0.998 0.002
M25.36 Other instability of joint (Lower leg)
0.000 0.998 0.002
I70.8 Atherosclerosis of other arteries
0.000 0.998 0.002
Y40.0 Penicillins
0.002 0.998 0.000
Z97.4 Presence of external hearing-aid
0.002 0.998 0.000
M23.80 Other internal derangements of knee (Multiple sites)
0.002 0.998 0.000
I67.1 Cerebral aneurysm, nonruptured
0.000 0.998 0.002
M25.3 Other instability of joint
0.000 0.998 0.002
M80.90 Unspecified osteoporosis with pathological fracture (Multiple sites)
0.002 0.998 0.000
I70.9 Generalised and unspecified atherosclerosis
0.000 0.998 0.002
H21.5 Other adhesions and disruptions of iris and ciliary body
0.000 0.998 0.002
J35.3 Hypertrophy of tonsils with hypertrophy of adenoids
0.000 0.998 0.002
I70.11 Atherosclerosis of renal artery (with gangrene)
0.000 0.998 0.002
J35.2 Hypertrophy of adenoids
0.000 0.998 0.002
I70.01 Atherosclerosis of aorta (with gangrene)
0.000 0.998 0.002
S64.2 Injury of radial nerve at wrist and hand level
0.002 0.998 0.000
M25.33 Other instability of joint (Forearm)
0.000 0.998 0.002
C90.0 Multiple myeloma
0.002 0.998 0.000
S00.2 Other superficial injuries of eyelid and periocular area
0.000 0.998 0.002
T24.0 Burn of unspecified degree of hip and lower limb, except ankle and foot
0.002 0.998 0.000
M24.23 Disorder of ligament (Forearm)
0.000 0.998 0.002
M82.10 Osteoporosis in endocrine disorders (Multiple sites)
0.000 0.998 0.002
M45.X7 Ankylosing spondylitis (Lumbosacral region)
0.002 0.998 0.000
N42.2 Atrophy of prostate
0.002 0.998 0.000
T24.2 Burn of second degree of hip and lower limb, except ankle and foot
0.002 0.998 0.000
M45.X9 Ankylosing spondylitis (Site unspecified)
0.002 0.998 0.000
M45.X6 Ankylosing spondylitis (Lumbar region)
0.002 0.998 0.000
Y40.1 Cefalosporins and other -lactam antibiotics
0.002 0.998 0.000
T24 Burn and corrosion of hip and lower limb, except ankle and foot
0.002 0.998 0.000
M45.X0 Ankylosing spondylitis (Multiple sites in spine)
0.002 0.998 0.000
T39.4 Antirheumatics, not elsewhere classified
0.000 0.998 0.002
T39.2 Pyrazolone derivatives
0.000 0.998 0.002
G43.1 Migraine with aura [classical migraine]
0.002 0.998 0.000
S12.2 Fracture of other specified cervical vertebra
0.002 0.998 0.000
T84.6 Infection and inflammatory reaction due to internal fixation device [any site]
0.002 0.998 0.000
L85 Other epidermal thickening
0.000 0.998 0.002
M45 Ankylosing spondylitis
0.002 0.998 0.000
W17 Other fall from one level to another
0.000 0.998 0.002
M62.86 Other specified disorders of muscle (Lower leg)
0.000 0.998 0.002
M45.X2 Ankylosing spondylitis (Cervical region)
0.002 0.998 0.000
I70.81 Atherosclerosis of other arteries (with gangrene)
0.000 0.998 0.001
I70.80 Atherosclerosis of other arteries (without gangrene)
0.000 0.998 0.001
M25.39 Other instability of joint (Site unspecified)
0.000 0.998 0.001
M25.38 Other instability of joint (Other)
0.000 0.998 0.001
M25.35 Other instability of joint (Pelvic region and thigh)
0.000 0.998 0.001
M25.34 Other instability of joint (Hand)
0.000 0.998 0.002
M25.32 Other instability of joint (Upper arm)
0.000 0.998 0.001
M25.30 Other instability of joint (Multiple sites)
0.000 0.998 0.001
D86.9 Sarcoidosis, unspecified
0.002 0.998 0.000
M80.9 Unspecified osteoporosis with pathological fracture
0.002 0.998 0.000
W17.6 Industrial and construction area
0.000 0.998 0.002
I24.9 Acute ischaemic heart disease, unspecified
0.002 0.998 0.000
I82.8 Embolism and thrombosis of other specified veins
0.000 0.998 0.002
K55.9 Vascular disorder of intestine, unspecified
0.000 0.998 0.002
I70.91 Generalized and unspecified atherosclerosis (with gangrene)
0.000 0.998 0.001
C45.0 Mesothelioma of pleura
0.002 0.998 0.000
M25.37 Other instability of joint (Ankle and foot)
0.000 0.998 0.001
W17.2 School, other institution and public administrative area
0.000 0.998 0.001
H21 Other disorders of iris and ciliary body
0.000 0.998 0.002
H69.9 Eustachian tube disorder, unspecified
0.002 0.998 0.000
T24.1 Burn of first degree of hip and lower limb, except ankle and foot
0.001 0.998 0.000
Y45.0 Opioids and related analgesics
0.000 0.998 0.002
I70.90 Generalized and unspecified atherosclerosis (without gangrene)
0.000 0.998 0.001
S64.0 Injury of ulnar nerve at wrist and hand level
0.001 0.998 0.000
Y85 Sequelae of transport accidents
0.000 0.998 0.001
H21.4 Pupillary membranes
0.000 0.998 0.001
J15.2 Pneumonia due to staphylococcus
0.001 0.998 0.000
K90.9 Intestinal malabsorption, unspecified
0.001 0.998 0.000
S64.1 Injury of median nerve at wrist and hand level
0.001 0.998 0.000
N26 Unspecified contracted kidney
0.000 0.998 0.001
M62.85 Other specified disorders of muscle (Pelvic region and thigh)
0.000 0.999 0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.